Dr. Aida Habtezion joined @Pfizer as our Chief Medical Officer during the height of the #COVID19 pandemic to help improve millions of lives. Learn more about her approach to patient-centricity and driving #equity in R&D. #PFEColleague https://t.co/6cy3KjHtNF
Dr. Aida Habtezion joined @Pfizer as our Chief Medical Officer during the height of the #COVID19 pandemic to help improve millions of lives. Learn more about her approach to patient-centricity and driving #equity in R&D. #PFEColleague https://t.co/w83Y4ECXlL
Our colleague Hector Cacique traveled over 300 kilometers in Argentina to ensure that one of our #Covid19 clinical trials could stay on track. Watch the full new episode in our video series here: #PFEColleague https://t.co/twD8QUGHQe
Our colleague Hector Cacique traveled over 300 kilometers in Argentina to ensure that one of our #Covid19 clinical trials could stay on track. Watch the full new episode in our "Moonshot: Incredible Stories Behind the Covid-19 Vaccine" video series here: https://t.co/995lYpm6pV
James manages temperature control logistics at @Pfizer. Hear why his role in safely delivering our products has earned him the nickname βIce Man.β #RealPeopleRealVoices#PFEColleague https://t.co/DcrB1BWOUK
#PfizerProud! (The Pfizer-BioNTech COVID-19 vaccine has not been approved or licensed by the U.S. FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16 and older. See conditions of use: https://t.co/pmeQX8BGor) #PFEColleague https://t.co/yxc12mSBPg
NEWS: The Pfizer-@BioNTech_Group#COVID19 vaccine has not been approved or licensed by the @US_FDA but has been authorized for emergency use to prevent COVID-19 in individuals 16 & older. See conditions of use: https://t.co/RbC0OwSEEi
Last week, @Pfizer submitted an Emergency Use Authorization request with @BioNTech_Group to the @FDA for our #COVID19 vaccine candidate. Our Angela Hwang, answers your questions about this latest milestone & what steps are still to come. #PFEColleague https://t.co/05CNkV2NrB
Evidence of efficacy, safety & consistent manufacturing are 3 requirements that @Pfizer must demonstrate to seek Emergency Use Authorization for its potential #COVID19 vaccine. Learn more about these key areas: #PFEColleague https://t.co/KqFmVQwqqK
Our CEO @AlbertBourla has written an open letter to provide clarity around the development of our investigational #COVID19 vaccine. You can read it here: #PFEColleague https://t.co/2qtvSKGw6h
I'm #PfizerProud to stand with our Chairman and CEO @AlbertBourla as he talks about what Pfizer is doing to build a safe and effective #COVID19 vaccine candidate and the need to build trust in the science. #PFEColleague https://t.co/rYsQo5Yr42
Monday September 7 is World Duchenne Awareness Day. Hear from Bert Bruce, our Vice President of Global Marketing for Rare Disease, on the importance of early testing and diagnosis. #WDAD2020#PFEColleague https://t.co/eCEmfTl2Iq
Our Chief Business Officer, John Young, spoke to the Energy & Commerce Committee yesterday to update them on our ongoing efforts to develop a #COVID19#vaccine. See what he had to say. #PfizerProud#PFEColleague#PFEColleague https://t.co/iaT0sAewUf
Exciting news about Pfizer and BioNTechβs #COVID19#vaccine candidate advancing to the next stage in clinical development. #PfizerProud#PFEColleague https://t.co/BwyLWPtQfF
Improving access to big data will also improve our efforts in the fight against COVID-19. Learn how Pfizer has joined the COVID-19 Healthcare Coalition: https://t.co/51KRH2RaDu #COVID19#PFEColleague https://t.co/C5Z2ImIKpy